Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Children’s Hospital of Philadelphia Neurofibromatosis Program


Address

The Children's Hospital of Philadelphia
3401 Civic Center Blvd
Philadelphia, PA 19104

Phone

215-590-7012

800 Number

1-800-879-2467

Description

The Children's Hospital of Philadelphia (CH0P) 501(c)(3) the oldest hospital in the United States dedicated exclusively to pediatrics, strives to be the world leader in the advancement of healthcare for children by integrating excellent patient care, innovative research and quality professional education into all of its programs. Children's Hospital is committed to researching and finding cures for chronic and fatal pediatric illnesses. Our physician-researchers draw on the latest available information about the human genome to customize therapies to variations in genetic makeup. Oncologists are working on therapeutic vaccines for children that teach patients' healthy cells to recognize and fight cancer. Other researchers are investigating prenatal stem-cell transplants to improve treatments for a variety of diseases including muscular dystrophy, leukemia and sickle cell disease. For new patient evaluation: Dr. Elaine Zackai, 215-590-2920, for follow-up services: Dr. Rachel Hachen, 215-590-0497, for questions regarding tumors: Dr. Jean Belasco, 215-590-2848 or 1-800-TRY-CHOP (1-800-879-2467).

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.